Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusceptio
Not Applicable
Recruiting
- Conditions
- Digestive SystemPaediatrics
- Registration Number
- PACTR201602001480323
- Lead Sponsor
- Cairo University Pediatric Surgery Dept
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Infantile Intussusception
Exclusion Criteria
Peritonitis
Pneumoperitoneum
Morbid patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain hydrocortisone's role in improving pneumatic reduction success rates for infantile intussusception?
How does hydrocortisone compare to standard-of-care treatments in infantile intussusception pneumatic reduction outcomes?
Are there specific biomarkers that predict response to hydrocortisone in pediatric intussusception cases?
What are the potential adverse events associated with hydrocortisone use in infantile intussusception pneumatic reduction?
What combination therapies or alternative corticosteroids show promise in treating infantile intussusception alongside pneumatic reduction?